Constitutive BAK/MCL1 complexes predict paclitaxel and S63845 sensitivity of ovarian cancer (vol 12, 1002, 2021)

被引：2
|
作者：
Liu, Dongyan
Hou, Xiaonan
Wu, Wangyu
Zafagnin, Valentina
Li, Yunjian
Correia, Cristina
Zhao, Zhiyang
Zhao, Chenggang
Liu, Zhirong
Zhang, Tao
Fang, Zhiyou
Wang, Hongzhi
Xu, Chao
Weroha, Saravut J.
Kaufmann, Scott H.
Dai, Haiming
机构：
[1] Anhui Province Key Laboratory of Medical Physics and Technology,Department of Molecular Pharmacology and Experimental Therapeutics
[2] Institute of Health & Medical Technology,undefined
[3] Hefei Institutes of Physical Science,undefined
[4] Chinese Academy of Sciences,undefined
[5] University of Science and Technology of China,undefined
[6] Hefei Cancer Hospital,undefined
[7] Chinese Academy of Sciences,undefined
[8] Division of Medical Oncology,undefined
[9] Mayo Clinic,undefined
[10] Second Affiliated Hospital of Anhui Medical University,undefined
[11] School of Basic Medical Sciences,undefined
[12] Anhui Medical University,undefined
[13] Mayo Clinic,undefined
[14] Division of Oncology Research,undefined
[15] Mayo Clinic,undefined
来源：
CELL DEATH & DISEASE | 2021年 / 12卷 / 11期
关键词：
D O I：
10.1038/s41419-021-04219-0
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页数：1
相关论文
共 10 条
  • [1] Constitutive BAK/MCL1 complexes predict paclitaxel and S63845 sensitivity of ovarian cancer
    Liu, Dongyan
    Hou, Xiaonan
    Wu, Wangyu
    Zafagnin, Valentina
    Li, Yunjian
    Correia, Cristina
    Zhao, Zhiyang
    Zhao, Chenggang
    Liu, Zhirong
    Zhang, Tao
    Fang, Zhiyou
    Wang, Hongzhi
    Xu, Chao
    Weroha, Saravut J.
    Kaufmann, Scott H.
    Dai, Haiming
    CELL DEATH & DISEASE, 2021, 12 (08)
  • [2] Constitutive BAK/MCL1 complexes predict paclitaxel and S63845 sensitivity of ovarian cancer
    Dongyan Liu
    Xiaonan Hou
    Wangyu Wu
    Valentina Zanfagnin
    Yunjian Li
    Cristina Correia
    Zhiyang Zhao
    Chenggang Zhao
    Zhirong Liu
    Tao Zhang
    Zhiyou Fang
    Hongzhi Wang
    Chao Xu
    Saravut J. Weroha
    Scott H. Kaufmann
    Haiming Dai
    Cell Death & Disease, 12
  • [3] Correction: Constitutive BAK/MCL1 complexes predict paclitaxel and S63845 sensitivity of ovarian cancer
    Dongyan Liu
    Xiaonan Hou
    Wangyu Wu
    Valentina Zafagnin
    Yunjian Li
    Cristina Correia
    Zhiyang Zhao
    Chenggang Zhao
    Zhirong Liu
    Tao Zhang
    Zhiyou Fang
    Hongzhi Wang
    Chao Xu
    Saravut J. Weroha
    Scott H. Kaufmann
    Haiming Dai
    Cell Death & Disease, 12
  • [4] The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models
    Kotschy, Andras
    Szlavik, Zoltan
    Murray, James
    Davidson, James
    Maragno, Ana Leticia
    Le Toumelin-Braizat, Gaetane
    Chanrion, Maia
    Kelly, Gemma L.
    Gong, Jia-Nan
    Moujalled, Donia M.
    Bruno, Alain
    Sekei, Marton C.
    Paczal, Attila
    Szabo, Zoltan B.
    Sipos, Szabolcs
    Radics, Gabor
    Proszenyak, Agnes
    Balint, Balazs
    Ondi, Levente
    Blasko, Gabor
    Robertson, Alan
    Surgenor, Allan
    Dokurno, Pawel
    Chen, Ijen
    Matassova, Natalia
    Smith, Julia
    Pedder, Christopher
    Graham, Christopher
    Studeny, Aurelie
    Lysiak-Auvity, Gaelle
    Girard, Anne-Marie
    Grave, Fabienne
    Segal, David
    Riffkin, Chris D.
    Pomilio, Giovanna
    Galbraith, Laura C. A.
    Aubrey, Brandon J.
    Brennan, Margs S.
    Herold, Marco J.
    Chang, Catherine
    Guasconi, Ghislaine
    Auquil, Nicolas C.
    Melchiore, Fabien
    Guigal-Stephan, Nolwen
    Lockhart, Brian
    Colland, Frederic
    Hickman, John A.
    Roberts, Andrew W.
    Huang, David C. S.
    Wei, Andrew H.
    NATURE, 2016, 538 (7626) : 477 - +
  • [5] The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models
    András Kotschy
    Zoltán Szlavik
    James Murray
    James Davidson
    Ana Leticia Maragno
    Gaëtane Le Toumelin-Braizat
    Maïa Chanrion
    Gemma L. Kelly
    Jia-Nan Gong
    Donia M. Moujalled
    Alain Bruno
    Márton Csekei
    Attila Paczal
    Zoltán B. Szabo
    Szabolcs Sipos
    Gábor Radics
    Agnes Proszenyak
    Balázs Balint
    Levente Ondi
    Gábor Blasko
    Alan Robertson
    Allan Surgenor
    Pawel Dokurno
    Ijen Chen
    Natalia Matassova
    Julia Smith
    Christopher Pedder
    Christopher Graham
    Aurélie Studeny
    Gaëlle Lysiak-Auvity
    Anne-Marie Girard
    Fabienne Gravé
    David Segal
    Chris D. Riffkin
    Giovanna Pomilio
    Laura C. A. Galbraith
    Brandon J. Aubrey
    Margs S. Brennan
    Marco J. Herold
    Catherine Chang
    Ghislaine Guasconi
    Nicolas Cauquil
    Fabien Melchiore
    Nolwen Guigal-Stephan
    Brian Lockhart
    Frédéric Colland
    John A. Hickman
    Andrew W. Roberts
    David C. S. Huang
    Andrew H. Wei
    Nature, 2016, 538 : 477 - 482
  • [6] Efficacy of MCL1 inhibitor S63845 in small cell lung cancer
    Yasuda, Yuto
    Ozasa, Hiroaki
    Tsuji, Takahiro
    Nomizo, Takashi
    Yamamoto, Tomoko
    Ajimizu, Hitomi
    Yoshida, Hironori
    Sakamori, Yuichi
    Hirai, Toyohiro
    Kim, Young Hak
    CANCER SCIENCE, 2018, 109 : 409 - 409
  • [7] Efficacy of MCL1 inhibitor S63845 in small cell lung cancer
    Yasuda, Yuto
    Ozasa, Hiroaki
    Tsuji, Takahiro
    Nomizo, Takashi
    Funazo, Tomoko
    Yoshida, Hironori
    Sakamori, Yuichi
    Hirai, Toyohiro
    Kim, Young Hak
    CANCER RESEARCH, 2018, 78 (13)
  • [8] In vitro and in vivo efficacy of MCL1 inhibitor S63845 in small cell lung cancer
    Yasuda, Yuto
    Ozasa, Hiroaki
    Tsuji, Takahiro
    Nomizo, Takashi
    Yamamoto, Tomoko
    Ajimizu, Hitomi
    Yoshida, Hironori
    Sakamori, Yuichi
    Hirai, Toyohiro
    Kim, Young Hak
    CANCER RESEARCH, 2019, 79 (13)
  • [9] MCL1 inhibitor S63845 delivered by follicle-stimulating hormone modified liposome potentiates carboplatin efficacy in ovarian cancer
    Zhang, Yanan
    Wang, Qingzhen
    Li, Wenxin
    Li, Xin
    Li, Yuqing
    Liu, Zhihua
    Zhou, Huige
    Luo, Aiping
    Chen, Chunying
    Li, Bin
    NANO TODAY, 2024, 59
  • [10] MCL1 Small Molecule Inhibitor S63845 Synergizes with Cisplatin in Basal-like Triple Negative Breast Cancer
    Acton, Alexus
    Placzek, William
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 385
1